| Metric | Q3-26 | Q3-25 |
|---|---|---|
| Revenue | 0.65 | 0.39 |
| Gross Profit | 0.53 | 0.15 |
| Pretax Income | -1.48 | -2.64 |
| Net Income | -1.48 | -2.64 |
| Diluted EPS | -0.07 | -0.20 |
- Net Income YoY
- +44.0%
Key highlights
- Quarterly revenue increased to $0.65 million from $0.39 million in Q3-25
- Net loss narrowed significantly to $1.48 million from $2.64 million
- Gross profit rose to $0.53 million, yielding a high gross margin for the quarter
- Diluted loss per share improved to $0.07 from $0.20 year-over-year
- Nine-month revenue reached $1.65 million, more than doubling the $0.73 million reported in 2025
How the Period Went
Firefly Neuroscience recorded revenue of $0.65 million for the third quarter of 2026, representing a significant 66% increase over the $0.39 million reported in the equivalent period of 2025. This growth in the top line was accompanied by an expansion in gross profit, which reached $0.53 million compared to just $0.15 million a year earlier. The company’s bottom line also showed marked improvement, with the net loss narrowing from $2.64 million in Q3-25 to $1.48 million in Q3-26. This 44% year-over-year reduction in net loss reflects both operational scaling and a more streamlined cost structure during the quarter.
Margins and Profitability
- Gross profit reached $0.53 million on $0.65 million in revenue, suggesting a highly scalable software model
- The net loss for the three-month period was reduced by $1.16 million compared to the previous year
- On a nine-month basis, the net loss fell to $5.47 million from a substantial $17.40 million in 2025
- Profitability was aided by the absence of large non-cash charges related to derivative fair value changes and debt settlements seen in 2025
- Diluted earnings per share improved by $0.13 per share year-over-year
Business Overview
Firefly Neuroscience operates within the technology sector, specifically focusing on the software-application industry. The company develops automated financial intelligence and diagnostic tools designed to process complex biological and operational data. Its core mission involves leveraging proprietary platforms to assist practitioners and organizations in making data-driven decisions. By serving end markets that require high-precision analytics, Firefly targets specialized sectors where automated data processing can reduce overhead and improve accuracy. The company continues to transition from early-stage development toward a more commercially active phase, as evidenced by its doubling of year-to-date revenue.
Financial Context
The company's market capitalization currently stands at approximately $14.88 million, reflecting its status as a micro-cap participant in the application software space. Despite the positive momentum in the Q3-26 results, the stock has faced volatility, recording a 21.49% decline over the past month and a 15.18% drop over the last quarter. However, the Relative Strength Index (RSI) of 42.3 indicates the security is trading in a neutral zone. With annual revenue of $1.142 million and quarterly revenue now reaching $0.65 million, the company is showing signs of sequential acceleration in its core business operations.
Down 6.7% since our story on 10 Nov: $0.95 when we broke it → $0.89 at the close on 16 Nov. Daily closing prices. Source: Yahoo Finance.
Show the prices
| 19 Oct | $1.00 |
|---|---|
| 20 Oct | $1.06 |
| 21 Oct | $1.05 |
| 22 Oct | $1.02 |
| 23 Oct | $0.92 |
| 26 Oct | $0.94 |
| 27 Oct | $1.00 |
| 28 Oct | $1.05 |
| 29 Oct | $1.03 |
| 30 Oct | $1.00 |
| 2 Nov | $0.99 |
| 3 Nov | $0.98 |
| 4 Nov | $1.04 |
| 5 Nov | $0.91 |
| 6 Nov | $0.91 |
| 9 Nov | $0.95 |
| 10 Nov | $0.98 |
| 11 Nov | $1.04 |
| 12 Nov | $0.96 |
| 13 Nov | $0.94 |
| 16 Nov | $0.89 |
| Share price | $0.95 |
|---|---|
| Market cap | $15M |
| Revenue (annual) | $1M |
| 1-month price change | -21.49% |
| Sector | TechnologySoftware - Application |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
SEC filing by Firefly Neuroscience, Inc. announcing its third quarter 2026 financial results.
Track FIREFLY NEUROSCIENCE, INC. live
Get the next FIREFLY NEUROSCIENCE, INC. SEC filing seconds after it lands.



